...
imrx-img

Immuneering Corp, Common Stock

IMRX

NMQ

$2.17

+$0.03

(1.4%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$67.69M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
186.00K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.40
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1 L
$8.41 H
$2.17

About Immuneering Corp, Common Stock

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIMRXSectorS&P500
1-Week Return4.33%-1.44%0.14%
1-Month Return14.21%-3.08%1%
3-Month Return81.59%-7.09%10.23%
6-Month Return45.64%-1.54%12.9%
1-Year Return-69.13%8.85%30.94%
3-Year Return-89.97%7.52%28.43%
5-Year Return-87.66%44.8%93%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue1.92M2.31M2.08M316.95K455.00[{"date":"2019-12-31","value":83.05,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.98,"profit":true},{"date":"2022-12-31","value":13.71,"profit":true},{"date":"2023-12-31","value":0.02,"profit":true}]
Cost of Revenue1.22M1.28M1.15M158.12K764.14K[{"date":"2019-12-31","value":95.52,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90.06,"profit":true},{"date":"2022-12-31","value":12.35,"profit":true},{"date":"2023-12-31","value":59.68,"profit":true}]
Gross Profit696.74K1.03M926.89K158.83K(764.14K)[{"date":"2019-12-31","value":67.57,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.88,"profit":true},{"date":"2022-12-31","value":15.4,"profit":true},{"date":"2023-12-31","value":-74.1,"profit":false}]
Gross Margin36.29%44.61%44.56%50.11%(167942.42%)[{"date":"2019-12-31","value":72.43,"profit":true},{"date":"2020-12-31","value":89.02,"profit":true},{"date":"2021-12-31","value":88.93,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-335136.22,"profit":false}]
Operating Expenses6.99M18.11M34.81M51.90M58.41M[{"date":"2019-12-31","value":11.96,"profit":true},{"date":"2020-12-31","value":31.01,"profit":true},{"date":"2021-12-31","value":59.6,"profit":true},{"date":"2022-12-31","value":88.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(6.29M)(17.08M)(33.89M)(51.74M)(58.41M)[{"date":"2019-12-31","value":-629101400,"profit":false},{"date":"2020-12-31","value":-1708255400,"profit":false},{"date":"2021-12-31","value":-3388606900,"profit":false},{"date":"2022-12-31","value":-5174486800,"profit":false},{"date":"2023-12-31","value":-5841288600,"profit":false}]
Total Non-Operating Income/Expense(2.84M)85.31K212.74K2.25M8.31M[{"date":"2019-12-31","value":-34.14,"profit":false},{"date":"2020-12-31","value":1.03,"profit":true},{"date":"2021-12-31","value":2.56,"profit":true},{"date":"2022-12-31","value":27.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(7.71M)(17.04M)(33.84M)(50.51M)(53.47M)[{"date":"2019-12-31","value":-770944800,"profit":false},{"date":"2020-12-31","value":-1703989800,"profit":false},{"date":"2021-12-31","value":-3384323300,"profit":false},{"date":"2022-12-31","value":-5051356800,"profit":false},{"date":"2023-12-31","value":-5347162200,"profit":false}]
Income Taxes351.30K(84.34K)(307.49K)(1.23M)2.00[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-24.01,"profit":false},{"date":"2021-12-31","value":-87.53,"profit":false},{"date":"2022-12-31","value":-350.63,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(8.06M)(16.96M)(33.54M)(49.28M)(53.47M)[{"date":"2019-12-31","value":-806075000,"profit":false},{"date":"2020-12-31","value":-1695556200,"profit":false},{"date":"2021-12-31","value":-3353574800,"profit":false},{"date":"2022-12-31","value":-4928179700,"profit":false},{"date":"2023-12-31","value":-5347162400,"profit":false}]
Income From Continuous Operations(7.71M)(17.04M)(33.54M)(50.51M)(51.63M)[{"date":"2019-12-31","value":-770944800,"profit":false},{"date":"2020-12-31","value":-1703989800,"profit":false},{"date":"2021-12-31","value":-3353574800,"profit":false},{"date":"2022-12-31","value":-5051356800,"profit":false},{"date":"2023-12-31","value":-5163419200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.06M)(17.04M)(33.54M)(49.28M)(53.47M)[{"date":"2019-12-31","value":-806075000,"profit":false},{"date":"2020-12-31","value":-1703989800,"profit":false},{"date":"2021-12-31","value":-3353574800,"profit":false},{"date":"2022-12-31","value":-4928179700,"profit":false},{"date":"2023-12-31","value":-5347162200,"profit":false}]
EPS (Diluted)(0.65)(1.26)(3.76)(1.92)(1.89)[{"date":"2019-12-31","value":-64.66,"profit":false},{"date":"2020-12-31","value":-125.85,"profit":false},{"date":"2021-12-31","value":-376,"profit":false},{"date":"2022-12-31","value":-192,"profit":false},{"date":"2023-12-31","value":-189,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IMRX
Cash Ratio 7.32
Current Ratio 7.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMRX
ROA (LTM) -37.42%
ROE (LTM) -61.81%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMRX
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMRX
Trailing PE NM
Forward PE NM
P/S (TTM) 563.62
P/B 1.17
Price/FCF NM
EV/R 191913.54
EV/Ebitda NM

FAQs

What is Immuneering Corp share price today?

Immuneering Corp (IMRX) share price today is $2.17

Can Indians buy Immuneering Corp shares?

Yes, Indians can buy shares of Immuneering Corp (IMRX) on Vested. To buy Immuneering Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Immuneering Corp be purchased?

Yes, you can purchase fractional shares of Immuneering Corp (IMRX) via the Vested app. You can start investing in Immuneering Corp (IMRX) with a minimum investment of $1.

How to invest in Immuneering Corp shares from India?

You can invest in shares of Immuneering Corp (IMRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Immuneering Corp shares
What is Immuneering Corp 52-week high and low stock price?

The 52-week high price of Immuneering Corp (IMRX) is $8.41. The 52-week low price of Immuneering Corp (IMRX) is $1.

What is Immuneering Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Immuneering Corp (IMRX) is

What is Immuneering Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Immuneering Corp (IMRX) is 1.17

What is Immuneering Corp dividend yield?

The dividend yield of Immuneering Corp (IMRX) is 0.00%

What is the Market Cap of Immuneering Corp?

The market capitalization of Immuneering Corp (IMRX) is $67.69M

What is Immuneering Corp’s stock symbol?

The stock symbol (or ticker) of Immuneering Corp is IMRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top